Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 66
- Live patents
- 0
- Shortage listings
- 7
- Countries
- 0
Alert
Drug shortage listings
7| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01) | Current | Available | 14 Jul 202324 Jun 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01) | Current | Limited Availability | 14 Jul 202324 Jun 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01) | Current | Limited Availability | 14 Jul 202324 Jun 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01) | Current | Available | 14 Jul 202324 Jun 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01) | Current | Limited Availability | 14 Jul 202324 Jun 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01) | Current | Limited Availability | 11 Jan 202424 Jun 2026 |
| Lisdexamfetamine Dimesylate CapsulePsychiatry | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01) | Current | Limited Availability | 14 Jul 202324 Jun 2026 |
Catalogue
Drug listings by form and route
6666 active NDC listings: 66 human prescription drug. By marketing category: ANDA 43, NDA AUTHORIZED GENERIC 16, NDA 7.
| Dosage form | NDCs |
|---|---|
| tablet | 28 |
| capsule, extended release | 13 |
| tablet, film coated, extended release | 8 |
| capsule | 7 |
| patch | 5 |
| solution | 2 |
| tablet, film coated | 2 |
| patch, extended release | 1 |
| Route | NDCs |
|---|---|
| oral | 56 |
| transdermal | 6 |
| sublingual | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| rhodes pharmaceuticals llc | 66 |
Catalogue
Marketed products
66| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| BUPRENORPHINE | BUPRENORPHINE | tablet, sublingual | 42858-501ANDA |
| BUPRENORPHINE | BUPRENORPHINE | tablet, sublingual | 42858-502ANDA |
| Buprenorphine | Buprenorphine | patch, transdermal | 42858-353NDA AUTHORIZED GENERIC |
| Buprenorphine | Buprenorphine | patch, transdermal | 42858-493NDA AUTHORIZED GENERIC |
| Buprenorphine | Buprenorphine | patch, transdermal | 42858-586NDA AUTHORIZED GENERIC |
| Buprenorphine | Buprenorphine | patch, transdermal | 42858-750NDA AUTHORIZED GENERIC |
| Buprenorphine | Buprenorphine | patch, transdermal | 42858-839NDA AUTHORIZED GENERIC |
| Buprenorphine and Naloxone | Buprenorphine and Naloxone | tablet, sublingual | 42858-601ANDA |
| Buprenorphine and Naloxone | Buprenorphine and Naloxone | tablet, sublingual | 42858-602ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | tablet, oral | 42858-721ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | tablet, oral | 42858-722ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | tablet, oral | 42858-723ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | tablet, oral | 42858-724ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | tablet, oral | 42858-725ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | tablet, oral | 42858-726ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate | tablet, oral | 42858-727ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE | capsule, extended release, oral | 42858-055ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE | capsule, extended release, oral | 42858-215ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE | capsule, extended release, oral | 42858-325ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE | capsule, extended release, oral | 42858-610ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE | capsule, extended release, oral | 42858-720ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE | capsule, extended release, oral | 42858-930ANDA |
| Dilaudid | hydromorphone hydrochloride | tablet, oral | 42858-122NDA |
| Dilaudid | hydromorphone hydrochloride | tablet, oral | 42858-234NDA |
| Dilaudid | hydromorphone hydrochloride | tablet, oral | 42858-338NDA |
| Dilaudid | hydromorphone hydrochloride | solution, oral | 42858-416NDA |
| Fenofibrate | Fenofibrate | tablet, film coated, oral | 42858-454ANDA |
| Fenofibrate | Fenofibrate | tablet, film coated, oral | 42858-660ANDA |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone Bitartrate and Acetaminophen | tablet, oral | 42858-201ANDA |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone Bitartrate and Acetaminophen | tablet, oral | 42858-202ANDA |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone Bitartrate and Acetaminophen | tablet, oral | 42858-203ANDA |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | tablet, oral | 42858-301NDA AUTHORIZED GENERIC |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | tablet, oral | 42858-302NDA AUTHORIZED GENERIC |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | tablet, oral | 42858-303NDA AUTHORIZED GENERIC |
| Hydromorphone Hydrochloride | Hydromorphone Hydrochloride | solution, oral | 42858-304NDA AUTHORIZED GENERIC |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 42858-161ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 42858-162ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 42858-163ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 42858-164ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 42858-165ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 42858-166ANDA |
| LISDEXAMFETAMINE DIMESYLATE | LISDEXAMFETAMINE DIMESYLATE | capsule, oral | 42858-167ANDA |
| MS Contin | morphine sulfate | tablet, film coated, extended release, oral | 42858-515NDA |
| MS Contin | morphine sulfate | tablet, film coated, extended release, oral | 42858-631NDA |
| MS Contin | morphine sulfate | tablet, film coated, extended release, oral | 42858-760NDA |
| Methylphenidate Hydrochloride | Methylphenidate Hydrochloride | capsule, extended release, oral | 42858-075NDA AUTHORIZED GENERIC |
| Methylphenidate Hydrochloride | Methylphenidate Hydrochloride | capsule, extended release, oral | 42858-076NDA AUTHORIZED GENERIC |
| Methylphenidate Hydrochloride | Methylphenidate Hydrochloride | capsule, extended release, oral | 42858-077NDA AUTHORIZED GENERIC |
| Methylphenidate Hydrochloride | Methylphenidate Hydrochloride | capsule, extended release, oral | 42858-078NDA AUTHORIZED GENERIC |
| Methylphenidate Hydrochloride | Methylphenidate Hydrochloride | capsule, extended release, oral | 42858-079NDA AUTHORIZED GENERIC |
| Methylphenidate Hydrochloride | Methylphenidate Hydrochloride | capsule, extended release, oral | 42858-080NDA AUTHORIZED GENERIC |
| Methylphenidate Hydrochloride | Methylphenidate Hydrochloride | capsule, extended release, oral | 42858-081NDA AUTHORIZED GENERIC |
| Morphine Sulfate Extended Release | Morphine Sulfate | tablet, film coated, extended release, oral | 42858-801ANDA |
| Morphine Sulfate Extended Release | Morphine Sulfate | tablet, film coated, extended release, oral | 42858-802ANDA |
| Morphine Sulfate Extended Release | Morphine Sulfate | tablet, film coated, extended release, oral | 42858-803ANDA |
| Morphine Sulfate Extended Release | Morphine Sulfate | tablet, film coated, extended release, oral | 42858-804ANDA |
| Morphine Sulfate Extended Release | Morphine Sulfate | tablet, film coated, extended release, oral | 42858-805ANDA |
| Oxycodone Hydrochloride | Oxycodone Hydrochloride | tablet, oral | 42858-001ANDA |
| Oxycodone Hydrochloride | Oxycodone Hydrochloride | tablet, oral | 42858-002ANDA |
| Oxycodone Hydrochloride | Oxycodone Hydrochloride | tablet, oral | 42858-003ANDA |
| Oxycodone Hydrochloride | Oxycodone Hydrochloride | tablet, oral | 42858-004ANDA |
| Oxycodone Hydrochloride | Oxycodone Hydrochloride | tablet, oral | 42858-005ANDA |
| Oxycodone and Acetaminophen | Oxycodone and Acetaminophen | tablet, oral | 42858-102ANDA |
| Oxycodone and Acetaminophen | Oxycodone and Acetaminophen | tablet, oral | 42858-103ANDA |
| Oxycodone and Acetaminophen | Oxycodone and Acetaminophen | tablet, oral | 42858-104ANDA |
| Scopolamine | Scopolamine | patch, extended release, transdermal | 42858-150ANDA |
Compare
Other companies listing dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
- Amneal Pharmaceuticals of New York, LLC14 sites · 227 NDC
- Elite Laboratories, Inc.1 site · 54 NDC
- Burel Pharmaceuticals, LLC0 sites · 30 NDC
Enquiry
Common questions
- Is Rhodes Pharmaceuticals LLC FDA approved?
- Rhodes Pharmaceuticals LLC holds no registered establishment of its own; 66 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Rhodes Pharmaceuticals LLC make?
- 66 products are listed under Rhodes Pharmaceuticals LLC in the openFDA NDC Directory, most often as tablet; capsule, extended release; tablet, film coated, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Rhodes Pharmaceuticals LLC products in shortage?
- 7 presentations are currently listed in the FDA drug shortage database under Rhodes Pharmaceuticals LLC, covering Lisdexamfetamine Dimesylate Capsule.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.